Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Omnicell (OMCL) Equity Average (2016 - 2025)

Historic Equity Average for Omnicell (OMCL) over the last 15 years, with Q3 2025 value amounting to $1.2 billion.

  • Omnicell's Equity Average rose 206.99% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 206.99%. This contributed to the annual value of $1.2 billion for FY2024, which is 488.02% up from last year.
  • Omnicell's Equity Average amounted to $1.2 billion in Q3 2025, which was up 206.99% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Omnicell's Equity Average peaked at $1.3 billion during Q2 2025, and registered a low of $989.3 million during Q1 2021.
  • For the 5-year period, Omnicell's Equity Average averaged around $1.2 billion, with its median value being $1.2 billion (2023).
  • In the last 5 years, Omnicell's Equity Average skyrocketed by 1982.7% in 2021 and then surged by 33.25% in 2022.
  • Quarter analysis of 5 years shows Omnicell's Equity Average stood at $1.1 billion in 2021, then grew by 0.33% to $1.1 billion in 2022, then grew by 4.89% to $1.2 billion in 2023, then rose by 4.13% to $1.2 billion in 2024, then increased by 0.4% to $1.2 billion in 2025.
  • Its Equity Average stands at $1.2 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.3 billion for Q1 2025.